Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Injectable Drug Delivery Market Size, Share, Price, Analysis and Forecasts, 2016 To 2022

Tuesday, October 4, 2016 22:43
% of readers think this story is Fact. Add your two cents.

(Before It's News)


GlobalData’s Medical Devices sector report, Injectable Drug Delivery – Medical Devices Pipeline Assessment, 2016″ provides an overview of Injectable Drug Delivery currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Browse full report with TOC@


- Extensive coverage of the Injectable Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Injectable Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

Request A Sample copy of This Report @

Table Of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 19
2 Introduction 20
2.1 Injectable Drug Delivery Overview 20
3 Products under Development 21
3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development 21
3.2 Injectable Drug Delivery – Pipeline Products by Segment 22
3.3 Injectable Drug Delivery – Pipeline Products by Territory 23
3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path 24
3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date 25
3.6 Injectable Drug Delivery – Ongoing Clinical Trials 26
4 Injectable Drug Delivery – Pipeline Products under Development by Companies 27
4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development 27
4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development 31
5 Injectable Drug Delivery Companies and Product Overview 35
5.1 Aciont Inc. Company Overview 35
5.2 Actavis Inc. Company Overview 37
5.3 AdrenaCard, Inc. Company Overview 38
5.4 Allergan, Inc. Company Overview 39
5.5 Alsensa ApS Company Overview 40
5.6 AMAG Pharmaceuticals, Inc. Company Overview 41
5.7 Amgen Inc. Company Overview 43
5.8 Antares Pharma, Inc. Company Overview 45
5.9 Anterion Therapeutics, Inc. (Inactive) Company Overview 51
5.10 Arnali, LLC Company Overview 54
5.11 Artemes Technologies, Inc. Company Overview 55
5.12 AstraZeneca Plc Company Overview 56
5.13 Atanse, Inc. Company Overview 58
5.14 AzureBio, S.L. Company Overview 60
5.15 Becton, Dickinson and Company Company Overview 61
5.16 Bespak Europe Ltd. Company Overview 65
5.17 Biodel Inc. Company Overview 68
5.18 BioMarin Pharmaceutical Inc. Company Overview 70
5.19 BioRestorative Therapies, Inc. Company Overview 72
5.20 Boston University Company Overview 74

To Get Discount On The Report @

Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.